SEC Form 4 · accession 0001127602-17-019314
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Merriman
Director
Period of report
May 22, 2017
Accepted (ET)
May 24, 2017 · 9:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2017 | M | 7,118 | $34.405 | A | 24,925 | D | |
| Common Stock | May 22, 2017 | S | 7,118 | $40.3087 | D | 17,807 | D | |
| Common Stock | May 22, 2017 | M | 10,353 | $30.5025 | A | 28,160 | D | |
| Common Stock | May 22, 2017 | S | 10,353 | $40.3363 | D | 17,807 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F1 | $34.405 | May 22, 2017 | M | 7,118 | D | Jul 21, 2012 | Jul 21, 2018 | Common Stock | 7,118 | 0 | D |
| Non-qualified Stock Option (Right to Buy) | $35.5025 | May 22, 2017 | M | 10,353 | D | Jul 23, 2015 | Jul 23, 2021 | Common Stock | 10,353 | 0 | D |
Explanation of responses
- F1Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.